New Post Public Reply Private Reply Replies (0) Message Board ← Newer Older → whytestocks Apr 1, 2022 at 3:35 PM 181 $ALT News Article - Altimmune Announces Initiation of 48-week Phase 2 MOMENTUM Trial of Pemvidutide in Obesity https://marketwirenews.com/news-releases/alti...99713.html My Twitter: WhyteStocks Newer Older
